WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks
WHO Director-General Tedros Adhanom Ghebreyesus said nearly a billion doses of vaccines had been secured for the COVAX programme to provide shots for poor- and middle-income countries, with 189 countries participating.

Soumya Swaminathan said the global health body could decide on Pfizer's vaccine candidate in the next "couple of weeks", and later said it could also review Moderna's and AstraZeneca's in a few weeks.
WHO approval could allow a vaccine to be deployed in some countries where national medical regulators have not yet been able to evaluate it. Swaminathan said at least 10 companies had expressed an interest or submitted a request for emergency approval for vaccine candidates.
WHO Director-General Tedros Adhanom Ghebreyesus said nearly a billion doses of vaccines had been secured for the COVAX programme to provide shots for poor- and middle-income countries, with 189 countries participating.
But several WHO officials noted that it would still take time to manufacture enough doses of vaccines to meet demand. Swaminathan said the supply was likely to be limited for the first half of 2021.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.